Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria
about
CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria.Glioma morphology and tumor-induced vascular alterations revealed in seven rodent glioma models by in vivo magnetic resonance imaging and angiography.Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brainIn the eye of experimental cerebral malaria.Role of the Lymphotoxin/LIGHT System in the Development and Maintenance of Reticular Networks and Vasculature in Lymphoid TissuesHost resistance to malaria: using mouse models to explore the host response.Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy.The immunological balance between host and parasite in malaria.Steroid Pulse Therapy May Mitigate Prolonged Neurological Manifestations after Eradication of Severe Plasmodium falciparum ParasitemiaThe Lymphotoxin β Receptor Is Essential for Upregulation of IFN-Induced Guanylate-Binding Proteins and Survival after Toxoplasma gondii Infection.Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections.Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.Protein kinase C-theta is required for development of experimental cerebral malaria.Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.The Glycosylphosphatidylinositol Transamidase Complex Subunit PbGPI16 of Plasmodium berghei Is Important for Inducing Experimental Cerebral Malaria
P2860
Q33873437-C4F80B3F-906D-46E4-AE6F-39C9A20B514EQ34041524-C4EDC9EC-7F42-462A-A116-68C34BB09F79Q34685370-CAC3EA5C-21B1-4DBA-9187-6584E1D051F8Q35168190-68EF2FBC-33F7-42EB-83AD-658D3E1E4C26Q37576573-D1D7774C-170D-4813-876D-023A78D3F39BQ37813458-EB21A499-171C-4056-BA50-547E311932FDQ37817830-39880700-E42B-4DE9-BD0B-3CD6ED70C7CCQ38666558-1B06FE50-A392-4803-BF31-A2B189A6D3ECQ38852173-B27AD4B2-868C-4943-BE08-2DCAE9697E3CQ40068799-CD5D96B7-4B04-4145-A01C-1F08D167A44AQ41106752-AC068AB7-3F56-4429-A7CE-86B921F448AEQ41482873-E7DCD271-9484-42BA-8D37-425847C649D9Q42045253-25CDE0B8-D185-4074-8272-3719A3422CC5Q47826573-BEB53168-837A-4A07-8605-6030B995E264Q56358564-03C247BD-41EB-4F7D-8EA9-F1A317BDD5FE
P2860
Both functional LTbeta receptor and TNF receptor 2 are required for the development of experimental cerebral malaria
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Both functional LTbeta recepto ...... experimental cerebral malaria
@ast
Both functional LTbeta recepto ...... experimental cerebral malaria
@en
Both functional LTbeta recepto ...... experimental cerebral malaria
@nl
type
label
Both functional LTbeta recepto ...... experimental cerebral malaria
@ast
Both functional LTbeta recepto ...... experimental cerebral malaria
@en
Both functional LTbeta recepto ...... experimental cerebral malaria
@nl
prefLabel
Both functional LTbeta recepto ...... experimental cerebral malaria
@ast
Both functional LTbeta recepto ...... experimental cerebral malaria
@en
Both functional LTbeta recepto ...... experimental cerebral malaria
@nl
P2093
P2860
P50
P921
P1433
P1476
Both functional LTbeta recepto ...... experimental cerebral malaria
@en
P2093
Anna M Hansen
Bich-Thuy Doan
Helen J Ball
Jean Claude Beloeil
Laurent Renia
Lizette Fick
Mathilde Fauconnier
Nicholas H Hunt
Paulo Loureiro de Sousa
Robert Menard
P2860
P356
10.1371/JOURNAL.PONE.0002608
P407
P577
2008-01-01T00:00:00Z